Carlos Guijarro

Cited by

	All	Since 2020
Citations	10893	5439
h-index	47	24
i10-index	99	51

1500

750

375

1125

19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202527 82 127 170 207 278 304 287 284 298 270 246 264 267 213 258 285 220 223 212 192 185 163 168 334 1455 1391 1048 814 250

Public access

View all

19 articles

3 articles

available

not available

Based on funding mandates

Co-authors

María VelascoHospital Universitario Fundación AlcorcónVerified email at fhalcorcon.es
Xavier Pintó SalaHospital Universitario de Bellvitge-IDIBELL; Universidad de Barcelona; CIBEROBNVerified email at bellvitgehospital.cat
Raquel Barba (ORCID: 0000-0002-14...PhD, Medicina Interna, Hospital Universitario Rey Juan Carlos; IIS-FJD; URJCVerified email at hospitalreyjuancarlos.es
Fernando Civeira MurilloVerified email at unizar.es
luis masanaProfessor of Medicine. Universitat Rovira i Virgili, Hospital Universitari Sant Joan. Reus (Spain)Verified email at urv.cat
Alberto OrtizIIS-Fundacion Jimenez Diaz, School of Medicine; UAM; Madrid, SpainVerified email at fjd.es
José R González JuanateyHead Cardiology Department, University Hospital Santiago de Compostel, SpainVerified email at sergas.es
Benjamin HerrerosProfesor de medicinaVerified email at ucm.es
José Lopez-MirandaProfesor de Medicina. Hospital Universitario Reina Sofía. IMIBIC. Universidad de Córdoba. CIBEROBNVerified email at uco.es
Elia Perez FernandezHospital Universitario Fundación AlcorcónVerified email at salud.madrid.org
Blanco-Colio LMIIS-Fundación Jiménez DíazVerified email at fjd.es
MARIA LUZ CUADRADOCatedrática de Neurología, Hospital Clínico San Carlos, Universidad Complutense de MadridVerified email at ucm.es
Miguel Camafort BabkowskiConsultor. Servicio de Medicina Interna. Hospital Clinic-IDIBAPS. Universidad de Barcelona. EspañaVerified email at clinic.cat
Federico PulidoUnidad VIH. Hospital Universitario 12 de Octubre, imas12. UCM. Madrid. SPAINVerified email at ucm.es
Antonio Zapatero (ORCID 0000-0003-...Hospital Universitario de Fuenlabrada ROR 04scbtr44.Universidad Rey Juan CarlosVerified email at salud.madrid.org
José TuñónHead Cardiology FJD; Full-Professor, Chairman of the Department of Medicine (Autónoma Univ. Madrid)Verified email at fjd.es
Santiago MorenoHospital Ramón y Cajal, University of Alcala, MadridVerified email at salud.madrid.org
Jose Ignacio MayordomoUniversity of Colorado DenverVerified email at unizar.es
José Luis Hernández HernándezHospital Marqués de Valdecilla. Universidad de CantabriaVerified email at scsalud.es
Antonio Hernández MijaresProfessor of Medicine. University of Valencia. SpainVerified email at uv.es

Carlos Guijarro

Other namesCarlos Guijarro Herraiz

Medicina Interna. Hospital Universitario Fundacion Alcorcon. Universidad Rey Juan Carlos

Verified email at salud.madrid.org

Medicina Interna. Riesgo vascular. Arteriosclerosis. COVID


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results WHOST Consortium The New England Journal of Medicine 384 (6), 497, 2021	2130*	2021
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results The New England Journal of Medicine 384 (6), 497, 2021	886	2021
Cardiovascular disease after renal transplantation. BL Kasiske, C Guijarro, ZA Massy, MR Wiederkehr, JZ Ma Journal of the American Society of Nephrology 7 (1), 158-165, 1996	833	1996
Transcription factor-κB (NF-κB) and renal disease C Guijarro, J Egido Kidney international 59 (2), 415-424, 2001	736	2001
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture C Guijarro, LM Blanco-Colio, M Ortego, C Alonso, A Ortiz, JJ Plaza, ... Circulation research 83 (5), 490-500, 1998	532	1998
Chronic renal allograft rejection: immunologic and nonimmunologic risk factors ZA Massy, C Guijarro, MR Wiederkehr, JZ Ma, BL Kasiske Kidney international 49 (2), 518-524, 1996	453	1996
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022	318	2022
Estándares SEA 2022 para el control global del riesgo cardiovascular JM Mostaza, X Pintó, P Armario, L Masana, JT Real, P Valdivielso, ... Clínica e investigación en arteriosclerosis 34 (3), 130-179, 2022	244	2022
Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis M Velasco, V Castilla, J Sanz, G Gaspar, E Condes, C Barros, M Cervero, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (2), 148-152, 2009	166	2009
Mortality among adult patients admitted to the hospital on weekends R Barba, JE Losa, M Velasco, C Guijarro, GG de Casasola, A Zapatero European Journal of Internal Medicine 17 (5), 322-324, 2006	160	2006
Clinical correlation between renal allograft failure and hyperlipidemia. C Guijarro, ZA Massy, BL Kasiske Kidney International Supplement, 1995	135	1995
Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats YS Park, C Guijarro, Y Kim, ZA Massy, BL Kasiske, WF Keane, ... American journal of kidney diseases 31 (1), 190-194, 1998	132	1998
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin ZA Massy, Y Kim, C Guijarro, BL Kasiske, WF Keane, MP O'Donnell Biochemical and Biophysical Research Communications 267 (2), 536-540, 2000	124	2000
The central role of nuclear factor-κB in mesangial cell activation ZA Massy, C Guijarro, MP O’Donnell, Y Kim, CE Kashtan, J Egido, ... Kidney International 56, S76-S79, 1999	116	1999
Relapse of Tuberculosis After Treatment in Human Immunodeficiency Virus—Infected Patients F Pulido, JM Peña, R Rubio, S Moreno, J González, C Guijarro, JR Costa, ... Archives of internal medicine 157 (2), 227-232, 1997	115	1997
Early glomerular changes in rats with dietary-induced hypercholesterolemia C Guijarro, BL Kasiske, Y Kim, MP O'Donnell, HS Lee, WF Keane American journal of kidney diseases 26 (1), 152-161, 1995	113	1995
Fatigue and dyspnoea as main persistent post-COVID-19 symptoms in previously hospitalized patients: related functional limitations and disability C Fernández-de-Las-Peñas, D Palacios-Cena, V Gomez-Mayordomo, ... Respiration 101 (2), 132-141, 2022	106	2022
Lovastatin inhibits lipopolysaccharide-induced NF-kB activation in human mesangial cells C Guijarro, Y Kim, CM Schoonover, ZA Massy, MP O'donnell, BL Kasiske, ... Nephrology Dialysis Transplantation 11 (6), 990-996, 1996	101	1996
Serum albumin and mortality after renal transplantation C Guijarro, ZA Massy, MR Wiederkehr, JZ Ma, BL Kasiske American journal of kidney diseases 27 (1), 117-123, 1996	100	1996
Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin SY Kim, C Guijarro, MP O'donnell, BL Kasiske, Y Kim, WF Keane Kidney international 48 (2), 363-371, 1995	100	1995

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors